Altimmune, Inc. (ALT) Misses Q4 EPS by 2c

Altimmune, Inc. (NASDAQ: ALT) reported Q4 EPS of ($0.27), $0.02 worse than the analyst estimate of ($0.25). Revenue for the quarter came in at $26 thousand versus the consensus estimate of $625 million.

For earnings history and earnings-related data on Altimmune, Inc. (ALT) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Danone SA (BN:FP) (DANOY) PT Raised to EUR63 at Deutsche Bank
• JPMorgan Starts Kanzhun Ltd (2076:HK) at Overweight